PA
CPF icon

PharVision Advisers’s Central Pacific Financial CPF Stock Holding History

PharVision Advisers’s Portfolio CPF Stock Details CPF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-9,098
Closed -$276K – 738
2025
Q3 		$276K Buy
+9,098
New +$266K 0.16% 276

Other funds holding CPF

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HAM
HoldCo Asset Management Fort Lauderdale, Florida $1.34B AUM 28.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
BCM
Basswood Capital Management New York $2.12B AUM 19.53% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

PharVision Advisers's CPF Position: Q4 2025 in Review

PharVision Advisers sold out of Central Pacific Financial (CPF) in Q4 2025, closing a stake of 9,098 shares — an estimated $276K sold.

PharVision Advisers first reported a position in CPF in Q3 2025 and held it in 1 quarter. The position peaked at $276K in Q3 2025. 188 funds tracked by Wall St. Rank hold CPF as of Q4 2025.

  • PharVision Advisers reported no remaining Central Pacific Financial position as of Q4 2025 after selling out during the quarter.
  • PharVision Advisers sold 9,098 Central Pacific Financial shares in Q4 2025, an estimated $276K.
  • PharVision Advisers first reported a position in Central Pacific Financial in Q3 2025 and held it in 1 quarter.
  • PharVision Advisers's Central Pacific Financial position peaked at $276K in Q3 2025.
  • 188 funds tracked by Wall St. Rank held Central Pacific Financial as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.